As startups slash prices to undercut competitors, the humanoid robotics market faces challenges in balancing costs, functionality, and investor demands.
It only cost $2 to take the Chicago Skyway toll road from Northwest Indiana into the city in 2004. Now it costs nearly four times as much to take the shortcut between Northwest Indiana and Chicago.
In the summer of 2018, 59-year-old David Gould went for his annual checkup, expecting to hear the usual: Everything looks fine. Instead, he was told that he was newly—and oddly—anemic.